CBD Monthly Roundup
The latest, biggest stories on scientific research, legal developments, and economic trends in the CBD world.
Summary: A new study reveals how to drastically improve absorption of CBD, while another finds that CBD can potentially help relieve symptoms of Parkinsons.
The poor bioavailability of orally-consumed CBD (as low as 4%) diminishes CBD’s therapeutic value. But in this small study, one group of subjects was given CBD fasted and the other group was given CBD with a high-fat burrito.
The researchers then measured the levels of CBD in the bloodstream of the subjects, and found some astounding results: those who took CBD with a high-fat meal had, on average, 14 times the maximum level of CBD as those who took it fasted. The total amount of CBD absorption in the high-fat group was four times that of the fasted group.
In this small study conducted by the University of Colorado, Parkinson’s patients were given 400+ mg of CBD daily. The participants experienced overall improvements in discomfort as well as physical symptoms like stiffness and slowness.
Highlight: The big takeaway from the review is that no one knows exactly how effective or safe CBD really is. The researchers argue that more research on humans is needed to confirm many of the health claims made on the packaging of products containing CBD, short for the Cannabis-derived compound cannabidiol.
“I think it’s really too early to just try anything that you get at the gas station,” Karen Mauck, M.D., co-author on the Mayo Clinic Proceedings journal and internist at the Mayo Clinic, tells Inverse. “Unless you’re a much more educated consumer getting it from these medical dispensaries, I think it’s too early to really take them for any sort of therapeutic effect right now.”
CBD Business Developments
Summary: One of the nation’s biggest CBD vendors responds to an FDA warning. A major new Gallup poll finds that CBD use and awareness is trending younger.
Last month, the FDA issued a warning to major CBD vendor Curaleaf about “unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” which led to Curaleaf retailers like CVS pulling the product from shelves.
Curaleaf’s executive chairman responded this month, saying “There was a tremendous amount of ambiguity and lack of transparency from the regulator about what the rules are,” Jordan said. “Congress passed the law in December, and yet the FDA has not come out and tied it to what you are allowed to do and what you are not allowed to do with the CBD market.”
Other findings of this new poll:
- 20% of Americans under 30 have used CBD
- Just 8% of Americans over 65 use CBD
- 21% of Americans in Western States use CBD, compared to 13% in the South and 15% in both the East and Midwest
The farmer’s market will feature local hemp and CBD vendors, educational events, and fun activities like making your own hemp florals and hemp-based clothing embroidery.
CBD Legal Developments
Summary: Another state bans CBD-infused food and drink, and the Pentagon follows other branches of the Department of Defense in completely prohibiting CBD use.
Following North Carolina and Ohio, Washington state has banned CBD-infused consumables in accordance with FDA rules.
This comes on the heels of similar bans from the Air Force, Coast Guard, and Navy. The new ruling states that servicemembers consuming CBD run the risk of testing positive for marijuana.